ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,927 | +6.2% | 71 | +20.3% | 0.00% | – |
Q2 2023 | $1,814 | +1579.6% | 59 | +1866.7% | 0.00% | – |
Q1 2023 | $108 | -98.6% | 3 | -98.4% | 0.00% | – |
Q4 2022 | $7,548 | – | 191 | +9450.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 2 | -99.7% | 0.00% | – |
Q3 2021 | $27,000 | – | 750 | +24900.0% | 0.00% | – |
Q2 2021 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 3 | -25.0% | 0.00% | – |
Q4 2020 | $0 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
Brown University | 621,759 | $24,777,000 | 6.04% |
Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |